Total Payments
$138,970
2024 Payments
$11,338
Companies
35
Transactions
370
Medicare Patients
5,662
Medicare Billing
$967,105
Payment Breakdown by Category
Other$98,098 (70.6%)
Travel$29,024 (20.9%)
Food & Beverage$11,719 (8.4%)
Education$129.98 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $89,937 | 48 | 64.7% |
| Travel and Lodging | $29,024 | 33 | 20.9% |
| Food and Beverage | $11,719 | 282 | 8.4% |
| Honoraria | $7,325 | 3 | 5.3% |
| Entertainment | $835.20 | 2 | 0.6% |
| Education | $129.98 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $110,747 | 203 | $0 (2024) |
| Fisher & Paykel Healthcare Inc | $23,678 | 37 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $1,215 | 40 | $0 (2024) |
| GlaxoSmithKline, LLC. | $596.91 | 22 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $286.65 | 15 | $0 (2023) |
| Edwards Lifesciences Corporation | $254.36 | 2 | $0 (2024) |
| Insmed, Inc. | $204.65 | 5 | $0 (2023) |
| Inari Medical, Inc. | $185.42 | 1 | $0 (2023) |
| Amgen Inc. | $181.31 | 4 | $0 (2024) |
| Baxter Healthcare | $165.25 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,338 | 31 | Actelion Pharmaceuticals US, Inc. ($10,635) |
| 2023 | $12,589 | 32 | Actelion Pharmaceuticals US, Inc. ($11,764) |
| 2022 | $41,252 | 74 | Actelion Pharmaceuticals US, Inc. ($40,640) |
| 2021 | $13,619 | 54 | Actelion Pharmaceuticals US, Inc. ($10,846) |
| 2020 | $5,268 | 29 | Actelion Pharmaceuticals US, Inc. ($4,987) |
| 2019 | $29,126 | 60 | Actelion Pharmaceuticals US, Inc. ($16,184) |
| 2018 | $16,628 | 51 | Actelion Pharmaceuticals US, Inc. ($10,649) |
| 2017 | $9,150 | 39 | Actelion Pharmaceuticals US, Inc. ($5,041) |
All Payment Transactions
370 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,940.00 | General |
| Category: Cardiology | ||||||
| 10/28/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Travel and Lodging | In-kind items and services | $737.10 | General |
| Category: Cardiology | ||||||
| 10/24/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $101.20 | General |
| Category: Cardiology | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: Respiratory | ||||||
| 10/04/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: Cardiology | ||||||
| 10/01/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $30.91 | General |
| Category: Cardiology | ||||||
| 09/30/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Travel and Lodging | In-kind items and services | $5.50 | General |
| Category: Cardiology | ||||||
| 09/20/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $31.46 | General |
| Category: General - Pain Management_NMD | ||||||
| 08/27/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $122.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/19/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,940.00 | General |
| Category: Cardiology | ||||||
| 08/16/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Travel and Lodging | In-kind items and services | $1,180.88 | General |
| Category: Cardiology | ||||||
| 08/15/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $136.95 | General |
| Category: Cardiology | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Respiratory | ||||||
| 07/17/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: Respiratory | ||||||
| 07/08/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: NEUROLOGY | ||||||
| 06/28/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Travel and Lodging | In-kind items and services | $5.50 | General |
| Category: Cardiology | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Respiratory | ||||||
| 04/24/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: Respiratory | ||||||
| 04/17/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Inflammation | ||||||
| 04/08/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $16.66 | General |
| Category: Medical Device | ||||||
| 03/28/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Respiratory | ||||||
| 03/25/2024 | Hikma Pharmaceuticals USA | Ryaltris (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 03/20/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $6.49 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,340 | 2,107 | $711,290 | $208,679 |
| 2022 | 19 | 1,228 | 2,155 | $736,780 | $244,857 |
| 2021 | 21 | 1,101 | 2,666 | $607,690 | $180,987 |
| 2020 | 23 | 1,993 | 14,672 | $938,829 | $332,582 |
Total Patients
5,662
Total Services
21,600
Medicare Billing
$967,105
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 211 | 549 | $373,320 | $93,405 | 25.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 155 | 512 | $113,152 | $32,051 | 28.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 126 | 126 | $39,190 | $20,623 | 52.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 92 | 145 | $46,255 | $13,656 | 29.5% |
| 94621 | Test for exercise-induced heart and lung stress | Office | 2023 | 89 | 89 | $21,644 | $10,397 | 48.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 80 | 93 | $14,912 | $8,898 | 59.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 50 | 50 | $30,950 | $6,861 | 22.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 30 | 30 | $12,660 | $3,098 | 24.5% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 28 | 28 | $7,299 | $2,868 | 39.3% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 39 | 41 | $15,979 | $2,232 | 14.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 52 | 52 | $4,179 | $2,182 | 52.2% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2023 | 16 | 16 | $8,500 | $2,099 | 24.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 93 | 93 | $4,920 | $1,890 | 38.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 26 | $2,825 | $1,829 | 64.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 60 | 60 | $5,351 | $1,735 | 32.4% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 51 | 51 | $3,317 | $1,661 | 50.1% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 101 | 101 | $2,972 | $1,412 | 47.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,633 | $1,208 | 45.9% |
| 94762 | Test to measure oxygen level in blood using ear or finger device continuously overnight | Office | 2023 | 32 | 34 | $1,231 | $573.30 | 46.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 227 | 697 | $473,960 | $122,267 | 25.8% |
| J0517 | Injection, benralizumab, 1 mg | Office | 2022 | 11 | 360 | $72,600 | $48,787 | 67.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 111 | 111 | $34,524 | $18,267 | 52.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 106 | 153 | $48,807 | $12,362 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 101 | $16,141 | $9,682 | 60.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 125 | 125 | $10,045 | $5,559 | 55.3% |
About Dr. Juan Pulido, MD
Dr. Juan Pulido, MD is a Pulmonary Disease healthcare provider based in Jacksonville Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1336293620.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Juan Pulido, MD has received a total of $138,970 in payments from pharmaceutical and medical device companies, with $11,338 received in 2024. These payments were reported across 370 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($89,937).
As a Medicare-enrolled provider, Pulido has provided services to 5,662 Medicare beneficiaries, totaling 21,600 services with total Medicare billing of $967,105. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Jacksonville Beach, FL
- Active Since 01/23/2007
- Last Updated 10/29/2018
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1336293620
Products in Payments
- UPTRAVI (Drug) $81,263
- Obstructive Sleep Apnea Device or Hospital Respiratory Equipment (Device) $17,966
- OPSUMIT (Drug) $7,901
- PT100US/myAIRVO 2 (Device) $2,275
- OPSUMIT MACITENTAN (Drug) $1,985
- FASENRA (Biological) $675.73
- NUCALA (Biological) $267.17
- OFEV (Drug) $222.06
- Arikayce (Drug) $204.65
- TEZSPIRE (Biological) $193.10
- FLOWTRIEVER CATHETER, S (Device) $185.42
- Hillrom - Life 2000 Ventilation System (Device) $165.25
- ANORO ELLIPTA (Drug) $146.04
- GORE PROPATEN Vascular Graft (Device) $141.29
- LifeVest (Device) $137.02
- HemoSphere (Device) $131.41
- superDimension (Device) $130.12
- FREESTYLE LIBRE 3 (Device) $129.62
- EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) $122.95
- WINREVAIR (Biological) $122.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.